Identification of distinct phenotypes and improving prognosis using metabolic biomarkers in COVID-19 patients.
Andressa SantanaGabriele da Silveira PrestesMarinara Dagostin da SilvaCarolina Saibro GirardiLucas Dos Santos SilvaJosé Claudio Fonseca MoreiraDaniel Pens GelainGlauco Adrieno WestphalEmil KupekRoger WalzFelipe Dal PizzolCristiane RitterPublished in: Critical care science (2024)
As a single biomarker, only cortisol was independently associated with mortality; however, metabolic biomarkers could improve mortality prediction when added to clinical parameters. Metabolic biomarker phenotypes were differentially distributed according to COVID-19 severity but were not associated with mortality.